Evidence map›Paper›PMID 34501444›Full record

ReviewJournal of clinical medicine2021

Fatigue in Systemic Lupus Erythematosus: An Update on Its Impact, Determinants and Therapeutic Management.

Lou Kawka, Aurélien Schlencker, Philippe Mertz, Thierry Martin, Laurent Arnaud

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 1 pooled it
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Observational
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Lou KawkaDepartment of Rheumatology, INSERM UMR-S1109, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Aurélien SchlenckerDepartment of Rheumatology, INSERM UMR-S1109, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Philippe MertzDepartment of Rheumatology, INSERM UMR-S1109, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.ORCID 0000-0002-9781-7388
Thierry MartinCentre National de Référence des Maladies Auto-Immunes Systémiques Rares Est Sud-Ouest (RESO), 67000 Strasbourg, France.
Laurent ArnaudDepartment of Rheumatology, INSERM UMR-S1109, Hôpitaux Universitaires de Strasbourg, 67000 Strasbourg, France.
Inserm · FRHôpitaux Universitaires de Strasbourg · FR

Funding

European Commission project INTERREG IV and V RhinFrench health ministry Centre National de Référence des Maladies Autoimmunes Systémiques Rares Est Sud-Ouest (RESO)
6 · The paper itself

Abstract

Fatigue is a complex and multifactorial phenomenon which is often neglected by clinicians. The aim of this review was to analyze the impact, determinants and management of fatigue in patients with Systemic Lupus Erythematosus (SLE). Fatigue is one of the most prevalent symptoms in SLE, reported by 67% to 90% of patients. It is also described as the most bothersome symptom, considering that it may impair key aspects of health-related quality of life, while also leading to employment disability. It is a multifactorial phenomenon involving psychological factors, pain, lifestyle factors such as reduced physical activity, whereas the contribution of disease activity remains controversial. The management of fatigue in patients with SLE should rely upon a person-centered approach, with targeted interventions. Some pharmacological treatments used to control disease activity have demonstrated beneficial effects upon fatigue and non-pharmacological therapies such as psychological interventions, pain reduction and lifestyle changes, and each of these should be incorporated into fatigue management in SLE.

Indexed as

fatiguequality of lifesystemic lupus erythematosus

Identifiers

PMID34501444
PMCPMC8432566
OpenAlexW3198107555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.